Trump unveils deal to expand coverage and lower costs on obesity drugs
President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 r
(Associated Press, 2025-11-06T17:14:55Z)